ImmunityBio Inc. (IBRX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ImmunityBio Inc.

    NASDAQ: IBRX · Real-Time Price · USD
    2.54
    0.04 (1.60%)
    At close: Oct 03, 2025, 3:59 PM
    2.58
    1.57%
    Pre-market: Oct 06, 2025, 08:28 AM EDT

    ImmunityBio Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.32 -4.38 -4.86 -6.76
    PEG Ratio
    		 0.09 -0.41 -0.31 -0.13
    PS Ratio
    		 121.07 4.11K 8.45K 2.53K
    PB Ratio
    		 -3.66 -4.35 -4.53 -9.77
    P/FCF Ratio
    		 -4.48 -6.43 -4.64 -7.68
    P/OCF Ratio
    		 -4.56 -6.96 -6.01 -8.62
    OCF/S Ratio
    		 -26.53 -589.64 -1.41K -293.81
    Debt / Equity Ratio
    		 -1.03 -1.24 -1.62 -2.67
    Quick Ratio
    		 3.21 5.05 0.23 0.91
    Current Ratio
    		 3.36 5.05 0.28 0.91
    Asset Turnover
    		 0.04 0.00 0.00 0.00
    Interest Coverage
    		 -2.23 -2.8 -5.53 -22.24
    Return on Equity
    		 0.85 0.99 0.93 1.44
    Return on Assets
    		 -1.08 -1.16 -1.15 -0.75
    Return on Invested Capital
    		 -1.02 -0.8 -1.19 -0.82
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 1.00 -99.8 1.00
    Net Profit Margin
    		 -28.05 -937.61 -1.74K -374.57
    Pretax Profit Margin
    		 -28.05 -938.73 -1.74K -374.56
    Operating Profit Margin
    		 -23.34 -582.4 -1.46K -353.62
    FCF Margin
    		 -27 -638.81 -1.82K -329.75
    EBITDA Margin
    		 -16.4 -701.26 -1.4K -337.67

    Add to Watchlist